Lanadelumab Is Well-Tolerated And Effective Across Patient Subgroups: Findings From The Help Open-Label Extension StudyM. Maurer,W. R. Lumry,H. H. Li,J. Jacobs,D. Soteres, P. Lu,J. Hao,A. BanerjiALLERGY(2020)引用 2|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要